Biden Administration Outlines Plan to Effectively Remove Patent Rights from Certain Prescription Medications Read more
Policy and Medicine Compliance Update – November 2023 Issue Features Patient Spokesman, Insulin Costs, SCOTUS Decision, and DOJ Safe Harbor for Mergers and Acquisitions. Read more
Policy and Medicine Compliance Update October 2023 Issue Features: Complex World of Medical Education, FDA Regulation of Laboratory Developed Tests, FDA Post Marketing Requirements, Distinct Roles of Legal and Compliance and Teva’s Generic Price Fixing Settlement Read more